Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.195 CAD | -7.14% | 0.00% | +34.48% |
Business Summary
Number of employees: 44
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Delivery (Services)
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +533.52% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +533.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anthony Tennyson
FOU | Founder | - | 31/12/19 |
Jonathan Held
FOU | Founder | 38 | 31/03/20 |
Shaun McNulty
CTO | Chief Tech/Sci/R&D Officer | - | - |
James Collins
COO | Chief Operating Officer | - | - |
David Nutt
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 16/05/22 | |
Gordo Whittaker
IRO | Public Communications Contact | - | - |
Naomi Junghae
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Carter
BRD | Director/Board Member | 63 | 13/12/21 |
Stephen Page
BRD | Director/Board Member | - | - |
George Scorsis
FOU | Founder | - | - |
Anthony Tennyson
FOU | Founder | - | 31/12/19 |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,591,197 | 35,330,516 ( 91.55 %) | 0 | 91.55 % |
Company contact information
Awakn Life Sciences Corp.
217 Queen Street West Suite 301
M5V 0R2, Toronto
+
http://www.awaknlifesciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+34.48% | 5.66M | |
+34.40% | 50.85B | |
+0.46% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.96% | 26.11B | |
-21.63% | 19.13B | |
+8.36% | 13.05B | |
+27.13% | 12.16B | |
+24.48% | 12.08B |
- Stock Market
- Equities
- AWKN Stock
- Company Awakn Life Sciences Corp.